ARTICLE
|
doi:10.20944/preprints202409.0840.v1
Subject:
Epidemiology And Infectious Diseases,
Medicine And Pharmacology
Keywords:
COVID-19; hyperinflammation; treatment evaluation; IL-1 receptor antagonist
Online: 11 September 2024 (12:37:39 CEST)